FDA re­jects Ab­b­Vie's in­fu­sion ther­a­py for Parkin­son's, re­quests more in­fo on pump de­vice

The FDA re­ject­ed Ab­b­Vie’s 24-hour in­fu­sion ther­a­py for Parkin­son’s, say­ing it needs more in­for­ma­tion on a de­vice used to ad­min­is­ter the treat­ment be­fore it can …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER